financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Upholds Sell Opinion On Shares Of Dayforce Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Upholds Sell Opinion On Shares Of Dayforce Inc.
Aug 8, 2025 12:34 AM

03:20 AM EDT, 08/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

After Q2 earnings, we keep our $46 target price, based on a P/E of 18.6x our 2026 EPS estimate, below its historical avg. and that of its peers, given our expectations of slower revenue growth due to a competitive landscape and uncertain hiring trends. We raise our 2025 EPS view by $0.14 to $2.20 (vs. consensus of $2.27) and 2026's by $0.15 to $2.47 (vs. consensus of $2.70). Despite a Q2 beat, shares are down 2% intraday, which we believe reflects investor concerns over slowing revenue growth trends that align with our previous cautionary outlook. Dayforce ( DAY ) recurring revenue growth of 14% in Q2 2025 was in line with Q1 2025 (+14%) but was a sharp deceleration from Q2 2024 (+20%). Our updated projections are for total revenue growth of 10% in 2025 and 9% in 2026, as we continue to see the impact of declining legacy Bureau revenue and flattening float income. Additionally, new user growth on the platform appears to be moderating. We expect live Dayforce ( DAY ) customers to grow 5% in both 2025 and 2026 vs. 8% in 2024.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Understanding Section 7702 plans
Understanding Section 7702 plans
Jun 11, 2024
Key takeaways Section 7702 of the IRS tax code outlines the criteria that life insurance policies must meet to qualify for tax advantages. The term '7702 plan' is a loose marketing term, not a specific type of life insurance policy. It typically refers to the tax treatment of cash value life insurance policies, which can include whole, universal, variable...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Jun 11, 2024
03:25 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target to $990 from $940, reflecting a 51.7x multiple on our 2025 EPS estimate, above LLY's historical forward P/E average. We maintain our 2024 EPS estimate at...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Jun 11, 2024
11:15 AM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month price target to $175 from $225 due to recent market movements, based on a forward P/E of 233x our 2025 EPS estimate of $0.75, a discount...
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Jun 11, 2024
01:05 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We set our 12-month target at $65, representing an estimated 2025 P/E of 43.3x. We initiate coverage at Hold, as we see adj-EPS growth to $1.10 in 2024 and $1.50...
Copyright 2023-2026 - www.financetom.com All Rights Reserved